PRHSX vs. FSMEX
Compare and contrast key facts about T. Rowe Price Health Sciences Fund (PRHSX) and Fidelity Select Medical Technology and Devices Portfolio (FSMEX).
PRHSX is managed by T. Rowe Price. It was launched on Dec 29, 1995. FSMEX is managed by Fidelity. It was launched on Apr 28, 1998.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PRHSX or FSMEX.
Key characteristics
| PRHSX | FSMEX | |
|---|---|---|
| YTD Return | 13.48% | 11.33% |
| 1Y Return | 19.59% | 33.58% |
| 3Y Return (Ann) | -4.20% | -7.34% |
| 5Y Return (Ann) | 4.69% | 3.88% |
| 10Y Return (Ann) | 3.25% | 6.62% |
| Sharpe Ratio | 1.43 | 2.18 |
| Sortino Ratio | 1.90 | 3.03 |
| Omega Ratio | 1.26 | 1.38 |
| Calmar Ratio | 0.70 | 0.81 |
| Martin Ratio | 6.94 | 8.08 |
| Ulcer Index | 2.91% | 4.23% |
| Daily Std Dev | 14.16% | 15.68% |
| Max Drawdown | -47.79% | -43.45% |
| Current Drawdown | -14.85% | -22.79% |
Correlation
The correlation between PRHSX and FSMEX is 0.82, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
PRHSX vs. FSMEX - Performance Comparison
In the year-to-date period, PRHSX achieves a 13.48% return, which is significantly higher than FSMEX's 11.33% return. Over the past 10 years, PRHSX has underperformed FSMEX with an annualized return of 3.25%, while FSMEX has yielded a comparatively higher 6.62% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
PRHSX vs. FSMEX - Expense Ratio Comparison
PRHSX has a 0.80% expense ratio, which is higher than FSMEX's 0.68% expense ratio.
Risk-Adjusted Performance
PRHSX vs. FSMEX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Sciences Fund (PRHSX) and Fidelity Select Medical Technology and Devices Portfolio (FSMEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PRHSX vs. FSMEX - Dividend Comparison
Neither PRHSX nor FSMEX has paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRHSX T. Rowe Price Health Sciences Fund | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
FSMEX Fidelity Select Medical Technology and Devices Portfolio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 11.71% | 5.17% | 9.84% |
Drawdowns
PRHSX vs. FSMEX - Drawdown Comparison
The maximum PRHSX drawdown since its inception was -47.79%, which is greater than FSMEX's maximum drawdown of -43.45%. Use the drawdown chart below to compare losses from any high point for PRHSX and FSMEX. For additional features, visit the drawdowns tool.
Volatility
PRHSX vs. FSMEX - Volatility Comparison
T. Rowe Price Health Sciences Fund (PRHSX) and Fidelity Select Medical Technology and Devices Portfolio (FSMEX) have volatilities of 3.84% and 4.01%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.